Global Dupuytren’s Disease Market Size & Outlook, 2022-2030
Global dupuytren’s disease market, 2018-2030 (US$M)
Related Markets
Global dupuytren’s disease market highlights
- The global dupuytren’s disease market generated a revenue of USD 4,134.9 million in 2022 and is expected to reach USD 5,872.0 million by 2030.
- The market is expected to grow at a CAGR (2023 - 2030) of 4.5% by 2030.
- In terms of segment, type ii accounted for a revenue of USD 2,584.2 million in 2022.
- Type II is the most lucrative disease type segment registering the fastest growth during the forecast period.
- In terms of region, Europe was the largest revenue generating market in 2022.
- Country-wise, Norway is expected to register the highest CAGR from 2023 to 2030.
Global data book summary
| Market revenue in 2022 | USD 4,134.9 million |
| Market revenue in 2030 | USD 5,872.0 million |
| Growth rate | 4.5% (CAGR from 2022 to 2030) |
| Largest segment | Type ii |
| Fastest growing segment | Type II |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Type I, Type II, Type III |
Other key industry trends
- In terms of revenue, the North America accounted for 14.8% of the global dupuytren’s disease market in 2022.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Norway is the fastest growing regional market and is projected to reach USD 54.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dupuytren’s Disease Market Scope
Dupuytren’s Disease Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Spear Pharmaceuticals | View profile | - | Randolph, New Jersey, United States, North America | http://www.spearpharma.com/ |
| Actiza Pharmaceutical Pvt. Ltd | View profile | 11-50 | https://www.actizapharma.com/ | |
| Nantong Jinghua Pharmaceutical | View profile | 1001-5000 | Nantong, Jiangsu, China, Asia | http://www.jinghuapharm.com/ |
| Hikma Pharmaceuticals PLC | View profile | 2150 | 1 New Burlington Place, London, United Kingdom, W1S 2HR | https://www.hikma.com |
| Endo Pharmaceuticals | View profile | 1001-5000 | Ballsbridge, Dublin, Ireland, Europe | http://www.endo.com |
| Eppendorf | View profile | 1001-5000 | Hamburg, Hamburg, Germany, Europe | https://dasgip.de |
| LEO Pharma | View profile | 1001-5000 | Parsippany, New Jersey, United States, North America | http://www.leo-pharma.us/ |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Fresenius SE & Co KGaA | View profile | 193865 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | https://www.fresenius.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Global dupuytren’s disease market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dupuytren’s disease market will help companies and investors design strategic landscapes.
Type ii was the largest segment with a revenue share of 62.5% in 2022. Horizon Databook has segmented the Global dupuytren’s disease market based on type i, type ii, type iii covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Dupuytren’s Disease Disease Type Outlook (Revenue, USD Million, 2018-2030)
- Type I
- Type III
- Type II
- Global Dupuytren’s Disease Type Outlook (Revenue, USD Million, 2018-2030)
- Diagnosis
- Treatment
- Global Dupuytren’s Disease End Use Outlook (Revenue, USD Million, 2018-2030)
- Academic & Research
- Other End Users
- Hospitals
- Clinics
Reasons to subscribe to Global dupuytren’s disease market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global dupuytren’s disease market databook
-
Our clientele includes a mix of dupuytren’s disease market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global dupuytren’s disease market, including forecasts for subscribers. This global databook contains high-level insights into Global dupuytren’s disease market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global dupuytrens disease market report size, by regions, 2018-2030 (US$M)
Top 10 countries: Dupuytrens disease market report size, 2022 (US$M)
Global dupuytrens disease market report share, by type, 2022 & 2030 (%, US$M)
Dupuytren’s disease market: Opportunity assessment by country
Global dupuytren’s disease market, by region, 2022 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
